The effect of comorbidity on primary care use during breast cancer chemotherapy: a population-based retrospective cohort study using CanIMPACT data

RL Walsh, AK Lofters, R Moineddin… - … Open Access Journal, 2021 - cmajopen.ca
Background: Patients with breast cancer visit their primary care physicians (PCPs) more
often during chemotherapy than before diagnosis, but the reasons are unclear. We …

Primary care use during, and wait times to receiving, adjuvant breast cancer chemotherapy: a population-based retrospective cohort study using CanIMPACT data

RL Feldman - 2020 - library-archives.canada.ca
OBJECTIVES: To determine how physical and/or mental comorbidities affect primary care
physician (PCP) use during adjuvant breast cancer chemotherapy and how PCP continuity …

Primary care use during, and wait times to receiving, adjuvant breast cancer chemotherapy: a population-based retrospective cohort study using CanIMPACT data

RL Walsh - 2020 - search.proquest.com
OBJECTIVES: To determine how physical and/or mental comorbidities affect primary care
physician (PCP) use during adjuvant breast cancer chemotherapy and how PCP continuity …

A population-based assessment of primary care visits during adjuvant chemotherapy for breast cancer

SJ Bastedo, MK Krzyzanowska, R Moineddin, L Yun… - Current …, 2017 - mdpi.com
Background: We used administrative health data to explore the impact of primary care
physician (pcp) visits on acute-care service utilization by women receiving adjuvant …

[HTML][HTML] Changes in primary care provider utilization by phase of care for women diagnosed with breast cancer: a CanIMPACT longitudinal cohort study

K Decker, R Moineddin, C Kendell, R Urquhart… - BMC Family …, 2019 - Springer
Abstract Background Primary care providers (PCPs) have always played an important role in
cancer diagnosis. There is increasing awareness of the importance of their role during …

[PDF][PDF] A population based assessment of primary care physician visits and acute care utilization among women receiving adjuvant chemotherapy for breast cancer

SJ Bastedo - 2014 - tspace.library.utoronto.ca
Objective: To gain a better understanding of the association between the care provided by
primary care physicians (PCPs) during active cancer treatment and acute care utilization …

Association between primary care and acute care services utilization in the year following diagnosis of breast cancer.

V Tran, R Hamal, X Hu, M Byrne, Y Cao - 2021 - ascopubs.org
e13522 Background: Primary care physicians (PCPs) play a pivotal role during cancer
diagnosis. Lack of access to primary care has been linked to worse outcomes including …

[HTML][HTML] Primary care continuity and wait times to receiving breast cancer chemotherapy: a population-based retrospective cohort study using CanIMPACT data

RL Walsh, A Lofters, R Moineddin, M Krzyzanowska… - Current …, 2021 - mdpi.com
(1) Background: Wait times to chemotherapy are associated with morbidity and mortality in
breast cancer patients; however, it is unclear how primary care physician (PCP) continuity …

Primary care physician use across the breast cancer care continuum: CanIMPACT study using Canadian administrative data

L Jiang, A Lofters, R Moineddin, K Decker… - Canadian Family …, 2016 - cfp.ca
Objective To describe primary care physician (PCP) use and continuity of PCP care across
the breast cancer care continuum. Design Population-based, retrospective cohort study …

[HTML][HTML] Role of the general practitioner during the active breast cancer treatment phase: an analysis of health care use

C Roorda, GH de Bock, WJ van der Veen… - Supportive Care in …, 2012 - Springer
Purpose Little is known about the actual involvement of the general practitioner (GP) during
the active breast cancer treatment phase. Therefore, this study explored (disease-specific) …